Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
 Disease Category: Myelodysplastic Syndromes (MDS)
Location: United States, ND

Trial Information

Myelodysplastic Syndrome (MDS)

To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with MDS

Patient Inclusion Criteria:

  • Diagnosis of MDS, 18+ years of age, adequate liver function, written informed consent

Patient Exclusion Criteria:

  • Have ever received any disease-modifying treatment MDS, Previously diagnosed with intermediate-2 or high risk MDS using the IPSS, prior history of leukemia, aplastic anemia, prior history of hematopoietic stem cell transplantation, active or uncontrolled infections, unstable angina, pregnant or breast feeding

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131
Email: tdavis.legacy@midconetwork.com

View Map

Research Center Information: Legacy Pharma Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.